Professional Documents
Culture Documents
NCM 112 Covid-19
NCM 112 Covid-19
DEFINITION OF COVID-19
Other current variants of concern also include:
A highly contagious respiratory disease caused
by the SARS-CoV-2 virus. SARS-CoV-2 is thought Alpha (B.1.1.7), first identified in the UK but
to spread from person to person through droplets which spread to more than 50 countries
released when an infected person coughs, sneezes, Beta (B.1.351), first identified in South Africa
or talks. It may also be spread by touching a surface but which has been detected in at least 20 other
with the virus on it and then touching one’s mouth, countries, including the UK
nose, or eyes, but this is less common. The most Gamma (P.1), first identified in Brazil but
common signs and symptoms of COVID-19 are which has spread to more than 10 other
fever, cough, and trouble breathing. Fatigue, muscle countries, including the UK
pain, chills, headache, sore throat, runny nose,
nausea or vomiting, diarrhea, and a loss of taste or Viruses mutate all the time and most changes are
smell may also occur. The signs and symptoms may inconsequential. Some even harm the virus. But
be mild or severe and usually appear 2 to 14 days others can make the disease more infectious or
after exposure to the SARS-CoV-2 virus. Some threatening - and these mutations tend to dominate.
people may not have any symptoms but are still
TRANSMISSION OF COVID19
able to spread the virus. Most people with COVID-
19 recover without needing special treatment. But Person-to-Person Transmission
other people are at higher risk of serious illness.
Experts believe the virus that causes COVID-19
Those at higher risk include older adults and people
spreads mainly from person to person. There are
with serious medical problems, such as heart, lung,
several ways this can happen:
or kidney disease, diabetes, cancer, or a weak
immune system. Serious illness may include life-
Droplets or aerosols. This is the most common
threatening pneumonia and organ failure. Research
transmission. When an infected person coughs,
is being done to treat COVID-19 and to prevent
sneezes, or talks, droplets or tiny particles called
infection with SARS-CoV-2. Also called
aerosols carry the virus into the air from their nose
coronavirus disease 19.
or mouth. Anyone who is within 6 feet of that
I. COVID-19 VARIANTS person can breathe it into their lungs.
Airborne transmission. Research shows that the
There are thousands of different types - or
virus can live in the air for up to 3 hours. It can get
variants - of Covid circulating across the world.
into your lungs if someone who has it breathes out
One of them, known as Delta or B.1.617.2, appears
and you breathe that air in. Experts are divided on
to be spreading quickly in many countries including
how often the virus spreads through the airborne
the UK, where it has become the dominant variant.
route and how much it contributes to the
pandemic.
Surface transmission. A less common method is
The UK classes Delta as a "variant of concern" - when you touch surfaces that someone who has
these are kept under the closest watch by health the virus has coughed or sneezed on. You may
officials. touch a countertop or doorknob that's
contaminated and then touch your nose, mouth,
or eyes. The virus can live on surfaces like plastic Containment of the infection with viral
and stainless steel for 2 to 3 days. To stop it, clean clearance in about 80% of patients in 10-14
and disinfect all counters, knobs, and other days
surfaces you and your family touch several times o It takes 5–6 days on average for symptoms to
a day. appear once a person is infected with the virus,
but it can take up to 14 days.
Involvement of the conducting airways
o Upper respiratory tract and migration into the
lower respiratory tract
SIGNS AND SYMPTOMS Invasion and infection of the type 2
Most common symptoms: Pulmonary alveolar epithelial cells via ACE-
fever 2
cough CYTOKINE STORM
tiredness An severe inflammatory response to
loss of taste or smell COVID-19 infection is followed by the
Less common symptoms: production of a high number of pro-
sore throat inflammatory cytokines, a phenomenon
headache known as "cytokine storm." The SARS-
aches and pains CoV-2 virus triggers a hyperactive
diarrhoea immunological response in the host,
a rash on skin, or discolouration of fingers resulting in an excessive inflammatory
or toes red or irritated eyes response.
Serious symptoms: o Chemo-attraction For Neutrophils, CD4 and
difficulty breathing or shortness of breath CD8 cells along with B cell differentiation
loss of speech or mobility, or confusion
chest pain o Host defence and attempt of viral clearance
PATHOPHYSIOLOGY
Virus entry into the Host Viral replication and Release of viral
Binding of the Inhaled SARS-CoV2 to the particles with resulting apoptosis of the host
o SARS-CoV-2 enters the upper respiratory tract With infection of the adjacent healthy
through respiratory aerosols and binds to nasal alveolar epithelial cells, with loss of
epithelial cells. The ACE-2 receptor is the both type 2 and type 1 pneumocytes
primary host receptor for viral entrance into Diffuse Alveolar Damage with Resulting
NURSING INTERVENTION